The impact of serum potassium concentration on mortality after liver transplantation: A cohort multicenter study

Transplantation

Volumn 88, Issue 3, 2009, Pages 402-410

  Dawwas, Muhammad F ^a   Lewsey, James D ^b   Watson, Christopher J ^a   Gimson, Alexander E ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cirrhosis; Complications; Hyperkalemia; Hypokalemia; Liver transplantation; Mortality; Potassium; Resource utilization

Indexed keywords

POTASSIUM;

ADULT; ARTICLE; CAUSE OF DEATH; CLINICAL TRIAL; FEMALE; HUMAN; HYPERKALEMIA; HYPOKALEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL MORTALITY;

ADULT; BIOLOGICAL MARKERS; FEMALE; GREAT BRITAIN; HUMANS; HYPERKALEMIA; HYPOKALEMIA; IRELAND; KAPLAN-MEIERS ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POTASSIUM; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 69449098529     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181aed8e4     Document Type: Article

References (67)

1. Shangraw RE. Metabolic issues in liver transplantation. Int Anesthesiol Clin 2006; 44: 1.
2. Decaux G, Soupart A, Cauchie P, et al. Potassium homeostasis in liver cirrhosis. Arch Intern Med 1988; 148: 547.
3. Trevisani F, Bernardi M, De Palma R, et al. Circadian variation in renal sodium and potassium handling in cirrhosis. The role of aldosterone, cortisol, sympathoadrenergic tone, and intratubular factors. Gastroenterology 1989; 96: 1187. (Pubitemid 19091137)
4. Gines A, Escorsell A, Gines P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229. (Pubitemid 23234041)
5. Sola-Vera J, Minana J, Ricart E, et al. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology 2003; 37: 1147. (Pubitemid 36538692)
6. Bustamante J, Rimola A, Ventura PJ, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30: 890. (Pubitemid 29248991)
7. Jarcuska P, Orolin M, Kovacova A, et al. Monitoring of selected "non-hepatic" laboratory parameters in hospitalized cirrhotic patients and their influence on prognosis. Bratisl Lek Listy 2004; 105: 18.
8. Terra C, Guevara M, Torre A, et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: Value of MELD score. Gastroenterology 2005; 129: 1944. (Pubitemid 41772972)
9. Wolfe RA, Merion RM, Roys EC, et al. Trends in organ donation and transplantation in the United States, 1998-2007.AmJ Transplant 2009; 9(4 Pt 2): 869.
10. Jacob M, Lewsey JD, Sharpin C, et al. Systematic review and validation of prognostic models in liver transplantation. Liver Transpl 2005; 11: 814. (Pubitemid 40975584)
11. Jacob M, Copley LP, Lewsey JD, et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004; 10: 903. (Pubitemid 38979261)
12. Weiner ID, Wingo CS. Hyperkalemia: A potential silent killer. J AmSoc Nephrol 1998; 9: 1535.
13. Weiner ID, Wingo CS. Hypokalemia - Consequences, causes, and correction. J Am Soc Nephrol 1997; 8: 1179.
14. Salmon J. Hyperkalaemia. In: Webb A, Shapiro M, Singer M, Suter P, eds., Oxford Textbook of critical care. Oxford, Oxford University Press 1999, pp 556.
15. Salmon J. Hypokalaemia. In: Webb A, Shapiro M, Singer M, Suter P, eds., Oxford textbook of critical care. Oxford, Oxford University Press 1999, pp 558.
16. Arroyo V, Rodes J, Gutierrez-Lizarraga MA, et al. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis 1976; 21: 249.
17. Londono MC, Guevara M, Rimola A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology 2006; 130: 1135.
18. Angeli P, Wong F, Watson H, et al. Hyponatremia in cirrhosis: Results of a patient population survey. Hepatology 2006; 44: 1535. (Pubitemid 44953659)
19. Dawwas MF, Lewsey JD, Neuberger JM, et al. The impact of serum sodium concentration on mortality after liver transplantation: A cohort multicenter study. Liver Transpl 2007; 13: 1115.
20. Roberts MS, Angus DC, Bryce CL, et al. Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS database. Liver Transpl 2004; 10: 886.
21. Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis 1978; 23: 398.
22. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy - Definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World congress of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716. (Pubitemid 34183979)
23. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649.
24. Jacob M, Copley LP, Lewsey JD, et al. Functional status of patients before liver transplantation as a predictor of posttransplant mortality. Transplantation 2005; 80: 52. (Pubitemid 40980895)
25. Moreau T, Le Minor M, Myquel P, et al. Estimation of the hazards ratio in two grouped samples. Biometrics 1985; 41: 245.
26. Hosmer DW Jr, Lemeshow S. Applied survival analysis regression modelling of time to event data. New York, Wiley 1999, pp 160.
27. Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: Parsimonious parametric modelling (with Discussion). Appl Stat 1994; 43: 429. (Pubitemid 24793414)
28. Sauerbrei W, Royston P. Building multivariable prognostic and diagnostic models: Transformation of the predictors by using fractional polynomials. J R Stat Soc Ser A Stat Soc 1999; 162: 71.
29. Levey AS, Bosch JP, Lewis JB, et al.; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130: 461.
30. Manjunath G, Sarnak MJ, Levey AS. Prediction equations to estimate glomerular filtration rate: An update. Curr Opin Nephrol Hypertens 2001; 10: 785. (Pubitemid 33043673)
31. Levey AS, Coresh J, Balk E, et al.; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139:137- 47; erratum in: Ann Intern Med 2003; 139: 605. (Pubitemid 38124565)
32. van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999; 18: 681.
33. Royston P. Multiple imputation of missing values. Stata J 2004; 4: 227.
34. Royston P. Multiple imputation of missing values: Update. Stata J 2005; 5: 1.
35. Austin PC, Brunner LJ. Inflation of the type I error rate when a continuous confounding variable is categorized in logistic regression analyses. Stat Med 2004; 23: 1159.
36. Altman DG. Categorizing continuous variables. In: Armitage P, Colton T, eds. Encyclopedia of biostatistics, [ed. 2] Chichester, England, John Wiley 2005, pp 708.
37. Fang J, Madhavan S, Cohen H, et al. Serum potassium and cardiovascular mortality. J Gen Intern Med 2000; 15: 885.
38. Vroonhof K, van Solinge WW, Rovers MM, et al. Differences in mortality on the basis of laboratory parameters in an unselected population at the Emergency Department. Clin Chem Lab Med 2005; 43: 536. (Pubitemid 41460631)
39. Skrifvars MB, Pettila V, Rosenberg PH, et al. A multiple logistic regression analysis of in-hospital factors related to survival at six months in patients resuscitated from out-of-hospital ventricular fibrillation. Resuscitation 2003; 59: 319. (Pubitemid 37500933)
40. Jones HJ, de Cossart L. Risk scoring in surgical patients. Br J Surg 1999; 86: 149.
41. Koperna T, Semmler D, Marian F. Risk stratification in emergency surgical patients: Is the APACHE II score a reliable marker of physiological impairment? Arch Surg 2001; 136: 55. (Pubitemid 32064121)
42. Ioannou GN. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl 2006; 12: 1594.
43. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 1179. (Pubitemid 34454015)
44. Gonwa TA, McBride MA, Anderson K, et al. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: Where will MELD lead us? Am J Transplant 2006; 6: 2651. (Pubitemid 44571685)
45. Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: Problems and pitfalls. Am J Kidney Dis 2003; 41: 269. (Pubitemid 36152445)
46. Poggio ED, Batty DS, Flechner SM. Evaluation of renal function in transplantation. Transplantation 2007; 84: 131.
47. Cholongitas E, Shusang V, Marelli L, et al. Review article: Renal function assessment in cirrhosis-Difficulties and alternative measurements. Aliment Pharmacol Ther 2007; 26: 969. (Pubitemid 47421959)
48. Milionis HJ, Elisaf MS. Hyperkalaemia in a patient with hepatic cirrhosis. Nephrol Dial Transplant 1999; 14: 2505.
49. Tsai MH, Peng YS, Chen YC, et al. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 2006; 43: 673.
50. Carmichael FJ, Lindop MJ, Farman JV. Anesthesia for hepatic transplantation: Cardiovascular and metabolic alterations and their management. Anesth Analg 1985; 64: 108.
51. Chapin JW, Wood RP, Hurlbert BJ, et al. Sources of increased serum potassium following reperfusion of liver allografts. Transplant Proc 1987; 19(4 suppl 3): 51.
52. Nakasuji M, Bookallil MJ. Pathophysiological mechanisms of postrevascularization hyperkalemia in orthotopic liver transplantation. Anesth Analg 2000; 91: 1351. (Pubitemid 30943873)
53. Ramsay MAE, Swygert T. Anesthesia for liver transplantation. In: Busuttil RW, Klintmalm GB, eds. Transplantation of the liver. Philadelphia, PA, Saunders 1996, pp 419.
54. Merritt WT. Metabolism and liver transplantation: Review of perioperative issues. Liver Transpl 2000; 6(4 suppl 1): S76.
55. Xia VW, Ghobrial RM, Du B, et al. Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg 2007; 105: 780. (Pubitemid 47300861)
56. Chen Z, Peto R, Collins R, et al. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 1991; 303: 276.
57. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434. (Pubitemid 23046633)
58. Baigent C, Keech A, Kearney PM, et al. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267; erratum in: Lancet 2005; 366: 1358.
59. Freitag MH, Vasan RS. What is normal blood pressure? Curr Opin Nephrol Hypertens 2003; 12: 285.
60. Manley S. Haemoglobin A1c-a marker for complications of type 2 diabetes: The experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 2003; 41: 1182. (Pubitemid 37265697)
61. Vasan RS, Evans JC, Larson MG, et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004; 351: 33.
62. Khaw KT, Wareham N, Bingham S, et al. Association of hemoglobin A1C with cardiovascular disease and mortality in adults: The European Prospective Investigation into Cancer in Norfolk. Ann Intern Med 2004; 141: 413. (Pubitemid 39281877)
63. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005; 90: 5483. (Pubitemid 41262320)
64. Axelrod DA, Guidinger MK, McCullough KP, et al. Association of center volume with outcome after liver and kidney transplantation. Am J Transplant 2004; 4: 920.
65. Burroughs AK, Sabin CA, Rolles K, et al.; European Liver Transplant Association. 3-month and 12-month mortality after first liver transplant in adults in Europe: Predictive models for outcome. Lancet 2006; 367: 225.
66. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783. (Pubitemid 43345017)
67. Cameron A, Busuttil RW. AASLD/ILTS transplant course: Is there an extended donor suitable for everyone? Liver Transpl 2005; 11(11 suppl 2): S2. (Pubitemid 43072606)